|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2001
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis
1 Adult Cystic Fibrosis Unit, Belfast City Hospital and 2 University of Ulster at Jordanstown, Northern Ireland
CORRESPONDENCE: S. Elborn, Adult Cystic Fibrosis Unit, Belfast City Hospital, Lisburn Rd, Co. Antrim, Northern Ireland. Fax: 44 1232263546
Keywords: cystic fibrosis, exercise capacity, inflammation, pulmonary function, quality of life
Received: February 7, 2000
Accepted September 13, 2000
The aim of the study was to determine the extent to which treatment induced changes in exercise capacity and quality of life (QoL) are related to spirometric measures of lung function and other measures of disease impairment.
Twenty patients admitted to hospital with an exacerbation of pulmonary disease were recruited. Measures of disease impairment, disability and QoL were obtained at the beginning and end of an intravenous course of antibiotic therapy.
Intravenous antibiotic treatment resulted in a significant improvement in all measures of disease impairment, disability and handicap. The only significant predictor of treatment induced change in exercise capacity was C-reactive protein (CRP) and this explained 28% of the variance in change in exercise capacity. In the case of QoL, two predictors (change in exercise capacity and sputum output) contributed significantly to the change in QoL and collectively explained 54% of the variance in QoL.
Lung function provides a limited index of treatment outcome. Exercise capacity and quality of life assessment have the potential to make a significant contribution to the decision making process regarding treatment choices in cystic fibrosis and should be measured directly if a comprehensive evaluation of the effect of treatment is required.
This article has been cited by other articles:
|
|
 |
|
  J Abbott Health-related quality of life measurement in cystic fibrosis: advances and limitations Chronic Respiratory Disease, February 1, 2009; 6(1): 31 - 41. [Abstract] [PDF]
|
|
|
|
|
|
J. Courtney, M. Kelly, A Watt, L Garske, J Bradley, M Ennis, and J. Elborn Quality of life and inflammation in exacerbations of bronchiectasis Chronic Respiratory Disease, August 1, 2008; 5(3): 161 - 168. [Abstract] [PDF]
|
|
|
|
 |
|
 J. D. Dodd, S. C. Barry, R. B. M. Barry, C. G. Gallagher, S. J. Skehan, and J. B. Masterson Thin-Section CT in Patients with Cystic Fibrosis: Correlation with Peak Exercise Capacity and Body Mass Index. Radiology, July 1, 2006; 240(1): 236 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M E Dodd and S A Prasad Physiotherapy management of cystic fibrosis Chronic Respiratory Disease, July 1, 2005; 2(3): 139 - 149. [Abstract] [PDF]
|
|
|
|
 |
|
 P. H. C. Klijn, A. Oudshoorn, C. K. van der Ent, J. van der Net, J. L. Kimpen, and P. J. M. Helders Effects of Anaerobic Training in Children With Cystic Fibrosis: A Randomized Controlled Study Chest, April 1, 2004; 125(4): 1299 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Holland, L Denehy, G Ntoumenopoulos, M T Naughton, and J W Wilson Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis Thorax, October 1, 2003; 58(10): 880 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Frangolias, J. Ruan, P. J. Wilcox, A. G. F. Davidson, L. T. K. Wong, Y. Berthiaume, R. Hennessey, A. Freitag, L. Pedder, M. Corey, et al. {alpha}1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Holland, J. W. Wilson, T. C. Kotsimbos, and M. T. Naughton Metabolic Alkalosis Contributes to Acute Hypercapnic Respiratory Failure in Adult Cystic Fibrosis Chest, August 1, 2003; 124(2): 490 - 493. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |